International Journal of Multiple Sclerosis and Related Disorders

International Journal of Multiple Sclerosis and  Related Disorders

International Journal of Multiple Sclerosis and Related Disorders

Open Access & Peer-Reviewed

Submit Manuscript

About The Journal

The International Journal of Multiple Sclerosis and Related Disorders (JSC) is an open access, peer-reviewed journal that publishes original research related to multiple sclerosis (MS) and its associated disorders. The journal covers all aspects of MS, including its clinical, epidemiological, genetic, immunological, neurological, and pathological features. The journal also provides a platform for researchers to discuss the latest findings, advancements and challenges in MS research.

JSC contains original articles as well as special sections for review articles and clinical trials. The journal also provides reviews on therapeutic breakthroughs, new treatments, clinical case studies, and recent advances in clinical practice. In addition, JSC also serves as a platform for discussions on the social and ethical implications of MS and its treatments.

Scope of JSC:
Autoimmune diseases of the central nervous system, Axo-glial pathobiology, Biomarkers, Clinical and neuroimaging, Clinical neurology, Epidemiology, Epidemology and genetics, Genetics epigenetics, Immune-mediated disease, Immunology, Manic-depressive illness, Microbiome, Multiple sclerosis, Myelin biology, Neurodegenerative diseases, Neuroimaging etc.
Remaining Scope can be viewed at Aim and Scope 

Submission Process
Authors are invited to submit their manuscripts through the online submission system. Manuscripts should be prepared in accordance with the instructions for authors. All manuscripts will be peer-reviewed and judged on their academic merit and relevance to the journal’s scope. Once accepted, the manuscripts will be published in the next available issue of the journal.
Article Processing Charge
JSC provides authors with an article processing charge (APC). This charge helps to cover the cost of publishing as it is an open access platform.

Editorial Board Members:
Derrick Robertson - University of South Florida
Cecilie Ammitzbà - Copenhagen University Hospital, Copenhagen, Denmark.
Fabiana Geraci - University of Palermo, Palermo, Italy
Jorge Matias-Guiu - Hospital Clinico San Carlos, Madrid, Institute of Neurociencias, Director
Anne Vejux - Laboratoire Bio-PeroxIL EA7270
Bitao Bu - Tongji Hospital, Tongji Medical College
Mazdak Ganjalikhani Hakemi - Isfahan University of Medical Sciences
Wang Yan - University of North Carolina at Chapel
Nevzat Uzuner - University Professor of Neurology & Algology, MD, FESO

1. I can not say enough about how good my experience working with OAP was. Submission is easy, and responses from the editorial staff respond promptly and professionally. The entire process from submission to PDF was completed in weeks rather than months.
Phillip Brumm - University of Wisconsin-Madison

2. My experience was very positive working with OAP. My manuscript review was very thorough and I appreciated the attention to detail. I would recommend submitting a manuscript.
Patricia Doyle-Baker - University of Calgary

Journals By Subject

Life Sciences
Medical Sciences